Back to Agenda
Session 5: Facilitating Access to Innovation in Asia / Practical pragmatic approaches
Session Chair(s)
Thean Soo Lo
Regulatory Affairs Management Consultant, Singapore
Audrey Ooi, MSc
Head- Business Development
Clinical Research Malaysia, Malaysia
Speaker(s)
Facilitating Regulatory Collaboration to Speed up Patient Access - Industry Perspective
Angelika Joos, MPharm
MSD, Belgium
Executive Director, Global Regulatory Policy
![Wittawat Viriyabancha](/_Images/member/Generic_Image_Missing-Profile.jpg)
Support for Innovation and Accelerated access
Wittawat Viriyabancha
Thai Food and Drug Administration, Thailand
Pharmacist Professional Level, Pre-Marketing Control Division,
Re-imaging the Regulatory Paradigm for Digital Health
Lesley Maloney, PharmD
Genentech, A Member of the Roche Group, United States
Global Regulatory Policy Lead - Digital Health and Integrated Solutions
![Mari Shirotani, PhD](/_Images/member/Generic_Image_Missing-Profile.jpg)
PMDA’s Activities to Promote Rapid Patient Access
Mari Shirotani, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Office Director, Office of Advanced Evaluation with Electronic Data
![Cynthia Sung Ang, MPH, RPh](/_Images/member/Generic_Image_Missing-Profile.jpg)
Data Analytics for Active Surveillance
Cynthia Sung Ang, MPH, RPh
Health Sciences Authority, Singapore
Regulatory Consultant
![Nicholas Leow Chun Wei](/_Images/member/Generic_Image_Missing-Profile.jpg)
Phase I Unit Accreditation for FIH Studies in Malaysia
Nicholas Leow Chun Wei
NPRA, Malaysia
Head of Section GCP
Have an account?